Compound: Ulixertinib

Drug Target: ERK1, ERK2

Drug Target pathway: ERK MAPK signaling

Dataset


Tissue specific analysis

Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Sanger Institute.